Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY24 results · Jan–Mar 2024
Max Healthcare Institute reported revenue from operations of ₹1,422.90 crore (up 17.2% from Q4 FY23) and net profit of ₹251.54 crore (up 0.2% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,422.90 | 1,214.51 | +17.2% | 1,334.97 | +6.6% |
| Other income | 45.25 | 40.22 | +12.5% | 46.02 | −1.7% |
| Total income | 1,468.15 | 1,254.73 | +17.0% | 1,380.99 | +6.3% |
| Profit before tax | 335.73 | 300.68 | +11.7% | 359.68 | −6.7% |
| Net profit for the period | 251.54 | 250.92 | +0.2% | 289.34 | −13.1% |
| Attributable to shareholders of the company | 250.69 | — | — | 289.34 | −13.4% |
| EPS, basic (₹) | 2.59 | 2.58 | +0.1% | 2.98 | −13.2% |
| Net margin (%) | 17.7 | 20.7 | 21.7 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 610.11 | 507.32 | +20.3% | 590.75 | +3.3% |
| Other income | 137.77 | 40.61 | +239.3% | 42.68 | +222.8% |
| Total income | 747.88 | 547.93 | +36.5% | 633.43 | +18.1% |
| Profit before tax | 290.62 | 150.96 | +92.5% | 203.33 | +42.9% |
| Net profit for the period | 241.77 | 126.37 | +91.3% | 158.12 | +52.9% |
| EPS, basic (₹) | 2.49 | 1.30 | +91.5% | 1.63 | +52.8% |
| Net margin (%) | 39.6 | 24.9 | 26.8 |
Consolidated
- Filed with BSE
- 23 May 2024, 12:07 IST
- Board meeting
- 22 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2024, 12:07 IST
- Board meeting
- 22 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE